Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects: evidence for injection interval of up to 2 months
Keywords:
Lanreotide Autogel pharmacokinetics
Neuroendocrine tumours
Citation:
Trocóniz IF, Cendrós JM, Peraire C, Ramis J, Garrido MJ, et al. Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects: evidence for injection interval of up to 2 months. Clin Pharmacokinet. 2009;48(1):51-62.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.